Clarity Pharmaceuticals (CLRPF, $1.56) was a top loser over the last three months, falling -1 to $1.56 per share. A.I.dvisor analyzed 832 stocks in the Biotechnology Industry for the 3-month period ending June 5, 2025, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.